Manchester Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.5K | Buy |
163
+2
| +1% | +$108 | ﹤0.01% | 779 |
|
|
2026
Q1 | $8.41K | Sell |
161
-25
| -13% | -$1.5K | ﹤0.01% | 816 |
|
|
2025
Q4 | $10.9K | Sell |
186
-4
| -2% | -$243 | ﹤0.01% | 768 |
|
|
2025
Q3 | $10.6K | Sell |
190
-3,366
| -95% | -$180K | ﹤0.01% | 865 |
|
|
2025
Q2 | $183K | Buy |
3,556
+679
| +24% | +$34.1K | 0.02% | 354 |
|
|
2025
Q1 | $169K | Buy |
2,877
+750
| +35% | +$50.8K | 0.02% | 358 |
|
|
2024
Q4 | $153K | Hold |
2,127
| – | – | 0.02% | 374 |
|
|
2024
Q3 | $170K | Buy |
2,127
+120
| +6% | +$9.02K | 0.02% | 358 |
|
|
2024
Q2 | $144K | Buy |
2,007
+268
| +15% | +$19.7K | 0.02% | 366 |
|
|
2024
Q1 | $122K | Buy |
1,739
+1,683
| +3,005% | +$120K | 0.02% | 381 |
|
|
2023
Q4 | $4.32K | Sell |
56
-1,628
| -97% | -$107K | ﹤0.01% | 724 |
|
|
2023
Q3 | $115K | Hold |
1,684
| – | – | 0.02% | 337 |
|
|
2023
Q2 | $137K | Buy |
1,684
+284
| +20% | +$22.8K | 0.02% | 312 |
|
|
2023
Q1 | $104K | Buy |
+1,400
| New | +$108K | 0.01% | 364 |
|
|
2022
Q4 | – | Sell |
-1,240
| Closed | -$88K | – | 1058 |
|
|
2022
Q3 | $88K | Hold |
1,240
| – | – | 0.02% | 311 |
|
|
2022
Q2 | $107K | Sell |
1,240
-360
| -23% | -$33.7K | 0.02% | 287 |
|
|
2022
Q1 | $173K | Hold |
1,600
| – | – | 0.02% | 264 |
|
|
2021
Q4 | $207K | Buy |
1,600
+180
| +13% | +$22.1K | 0.03% | 264 |
|
|
2021
Q3 | $172K | Buy |
1,420
+1,396
| +5,817% | +$170K | 0.02% | 296 |
|
|
2021
Q2 | $3K | Buy |
+24
| New | +$2.53K | ﹤0.01% | 649 |
|
|
2021
Q1 | – | Sell |
-12
| Closed | -$1K | – | 781 |
|
|
2020
Q4 | $1K | Buy |
+12
| New | +$869 | ﹤0.01% | 703 |
|
|
2016
Q1 | – | Sell |
-3,000
| Closed | -$68K | – | 663 |
|
|
2015
Q4 | $68K | Hold |
3,000
| – | – | 0.01% | 391 |
|
|
2015
Q3 | $69K | Buy |
+3,000
| New | +$75.2K | 0.01% | 364 |
|
|
2015
Q1 | – | Sell |
-1,400
| Closed | -$32K | – | 848 |
|
|
2014
Q4 | $32K | Sell |
1,400
-1,400
| -50% | -$32K | ﹤0.01% | 809 |
|
|
2014
Q3 | $65K | Hold |
2,800
| – | – | 0.01% | 677 |
|
|
2014
Q2 | $65K | Hold |
2,800
| – | – | 0.01% | 656 |
|
|
2014
Q1 | $60K | Buy |
2,800
+1,400
| +100% | +$31.5K | 0.01% | 621 |
|
|
2013
Q4 | $33K | Sell |
1,400
-1,600
| -53% | -$34.7K | 0.01% | 655 |
|
|
2013
Q3 | $60K | Hold |
3,000
| – | – | 0.01% | 570 |
|
|
2013
Q2 | $52K | Buy |
+3,000
| New | +$49.8K | 0.01% | 590 |
|
Other funds holding TECH
HI
Manchester Capital Management's TECH Position: Q2 2026 in Review
Manchester Capital Management increased its Bio-Techne (TECH) stake by 1.2% in Q2 2026, buying an estimated $108 and bringing the position to 163 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #779.
Manchester Capital Management first reported a position in TECH in Q2 2013 and has held it in 30 quarters since. The position peaked at $207K in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Manchester Capital Management held 163 shares of Bio-Techne worth $11.5K as of Q2 2026.
- Manchester Capital Management bought 2 Bio-Techne shares in Q2 2026, an estimated $108.
- Bio-Techne made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #779 holding.
- Manchester Capital Management first reported a position in Bio-Techne in Q2 2013 and has held it in 30 quarters since.
- Manchester Capital Management's Bio-Techne position peaked at $207K in Q4 2021.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.